Cargando…
An Emerging Treatment Alternative for Anemia in Chronic Kidney Disease Patients: A Review of Daprodustat
This article reviews an emerging therapeutic agent, which is currently in phase III development for the treatment of anemia secondary to chronic kidney disease, covering promising phase II results, drug characteristics, and the current phase III trials, which, if approved, may significantly impact t...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5778168/ https://www.ncbi.nlm.nih.gov/pubmed/29285707 http://dx.doi.org/10.1007/s12325-017-0655-z |
_version_ | 1783294307844751360 |
---|---|
author | Becker, Kimberly A. Jones, John J. |
author_facet | Becker, Kimberly A. Jones, John J. |
author_sort | Becker, Kimberly A. |
collection | PubMed |
description | This article reviews an emerging therapeutic agent, which is currently in phase III development for the treatment of anemia secondary to chronic kidney disease, covering promising phase II results, drug characteristics, and the current phase III trials, which, if approved, may significantly impact the management of anemia in this patient population. |
format | Online Article Text |
id | pubmed-5778168 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Springer Healthcare |
record_format | MEDLINE/PubMed |
spelling | pubmed-57781682018-02-01 An Emerging Treatment Alternative for Anemia in Chronic Kidney Disease Patients: A Review of Daprodustat Becker, Kimberly A. Jones, John J. Adv Ther Review This article reviews an emerging therapeutic agent, which is currently in phase III development for the treatment of anemia secondary to chronic kidney disease, covering promising phase II results, drug characteristics, and the current phase III trials, which, if approved, may significantly impact the management of anemia in this patient population. Springer Healthcare 2017-12-28 2018 /pmc/articles/PMC5778168/ /pubmed/29285707 http://dx.doi.org/10.1007/s12325-017-0655-z Text en © The Author(s) 2017 https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) ), which permits any non-commercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
spellingShingle | Review Becker, Kimberly A. Jones, John J. An Emerging Treatment Alternative for Anemia in Chronic Kidney Disease Patients: A Review of Daprodustat |
title | An Emerging Treatment Alternative for Anemia in Chronic Kidney Disease Patients: A Review of Daprodustat |
title_full | An Emerging Treatment Alternative for Anemia in Chronic Kidney Disease Patients: A Review of Daprodustat |
title_fullStr | An Emerging Treatment Alternative for Anemia in Chronic Kidney Disease Patients: A Review of Daprodustat |
title_full_unstemmed | An Emerging Treatment Alternative for Anemia in Chronic Kidney Disease Patients: A Review of Daprodustat |
title_short | An Emerging Treatment Alternative for Anemia in Chronic Kidney Disease Patients: A Review of Daprodustat |
title_sort | emerging treatment alternative for anemia in chronic kidney disease patients: a review of daprodustat |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5778168/ https://www.ncbi.nlm.nih.gov/pubmed/29285707 http://dx.doi.org/10.1007/s12325-017-0655-z |
work_keys_str_mv | AT beckerkimberlya anemergingtreatmentalternativeforanemiainchronickidneydiseasepatientsareviewofdaprodustat AT jonesjohnj anemergingtreatmentalternativeforanemiainchronickidneydiseasepatientsareviewofdaprodustat AT beckerkimberlya emergingtreatmentalternativeforanemiainchronickidneydiseasepatientsareviewofdaprodustat AT jonesjohnj emergingtreatmentalternativeforanemiainchronickidneydiseasepatientsareviewofdaprodustat |